ACE1-I/D Polymorphism in Patients With Severe COVID-19

2Cellular and Molecular Research Center, Research Institute for health development & Department of Molecular Medicine and Genetics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Journal of Cellular & Molecular Anesthesia:Vol. 8, issue 3; e149285

Published online:Feb 28, 2023

Article type:Research Article

How to Cite:Fouzieh KarimiVahedeh HosseiniAbbas AhmadiFahimeh Ranjbar KermaniShirin FerdowsiACE1-I/D Polymorphism in Patients With Severe COVID-19.J Cell Mol Anesth.8(3):e149285.https://doi.org/10.22037/jcma.v8i3.40994.

Abstract

Background: In several studies, insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme 1 (ACE1) gene is described as a genetic risk factor for coronavirus disease 2019 (COVID-19) infection. However, in some studies, this contribution is not confirmed. Therefore, this study aimed to evaluate the genotypic and allelic frequency of ACE1-D/I in Kurdish patients with severe COVID-19 in Iran. Methods: A total of 95 patients with PCR positive-COVID-19 were enrolled in this cross-sectional study. Genomic DNA was extracted from peripheral blood leucocytes using the salting out method. All cases were genotyped for ACE1-I/D polymorphism using polymerase chain reaction (PCR). Death percentage from COVID-19 after two months? follow-up was analyzed.?Results: Of?the 95 patients, 48 were female (50.5%) and 47 were male (49.5%) with a mean age of 61.9?18.7 years. The ID genotype was the most prevalent (52.6%) followed by DD (32.6%) and II (14.7%). The D and I allele frequencies were 58.9%, and 41.1%, respectively. The D allele frequency was higher in patients with SpO2?90% (P = 0.048). The mortality percentage was 18.9% (8 females and 10 males). The frequency of the DD, ID, and II genotypes in patients who died from COVID-19 was 27.7%, 61,1%, and 11.1%. Conclusions: Our results indicated that the ACE1- D allele can be a genetic risk factor in COVID-19 patients. Further studies on different ethnicities and geographical regions are needed to evaluate this polymorphism in COVID-19 infection.

Keywords

Coronavirus 19 (COVID-19)

Angiotensin 1 converting enzyme (ACE1)

I / D polymorphism

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Fouzieh Karimi:[PubMed][Scholar]
Vahedeh Hosseini:[PubMed][Scholar]
Abbas Ahmadi:[PubMed][Scholar]
Fahimeh Ranjbar Kermani:[PubMed][Scholar]
Shirin Ferdowsi:[PubMed][Scholar]